The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Williams, Jonathan Gareth
    Chemist born in February 1963
    Individual (19 offsprings)
    Officer
    2020-09-22 ~ now
    OF - Director → CIF 0
  • 2
    Jordison, Louisa Elizabeth
    Chief Financial Officer born in October 1978
    Individual (16 offsprings)
    Officer
    2021-11-01 ~ now
    OF - Director → CIF 0
  • 3
    Hirst, Simon Christopher
    Director born in April 1964
    Individual (22 offsprings)
    Officer
    2020-09-22 ~ now
    OF - Director → CIF 0
  • 4
    SYGNATURE CHEMICAL SERVICES LIMITED - 2011-09-07
    The Discovery Building Biocity, Pennyfoot Street, Nottingham, Nottinghamshire, United Kingdom
    Active Corporate (4 parents, 4 offsprings)
    Person with significant control
    2020-09-22 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 7
  • 1
    Cruwys, Simon, Dr
    Scientist born in July 1965
    Individual (1 offspring)
    Officer
    2011-02-24 ~ 2011-05-24
    OF - Director → CIF 0
  • 2
    Cicmil, Milenko, Dr
    Scientist born in September 1967
    Individual
    Officer
    2011-02-24 ~ 2011-05-24
    OF - Director → CIF 0
  • 3
    Crocker, Glenn, Dr
    Company Director born in March 1964
    Individual (37 offsprings)
    Officer
    2011-12-09 ~ 2020-09-22
    OF - Director → CIF 0
  • 4
    Overton, Paul Douglas
    Chief Commercial Officer born in October 1965
    Individual
    Officer
    2021-01-01 ~ 2024-05-20
    OF - Director → CIF 0
  • 5
    Dixon, John, Dr
    Independent Consultant born in February 1946
    Individual (3 offsprings)
    Officer
    2011-12-09 ~ 2020-09-22
    OF - Director → CIF 0
  • 6
    Tabiner, Victoria Jane
    Chief Financial Officer born in September 1971
    Individual (5 offsprings)
    Officer
    2020-09-22 ~ 2021-10-31
    OF - Director → CIF 0
  • 7
    Weaver, Richard, Dr
    Scientist born in October 1969
    Individual (3 offsprings)
    Officer
    2011-02-24 ~ 2020-09-22
    OF - Director → CIF 0
    Dr Richard Weaver
    Born in October 1969
    Individual (3 offsprings)
    Person with significant control
    2016-04-06 ~ 2020-09-22
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
parent relation
Company in focus

XENOGESIS LIMITED

Previous name
FULLY INTEGRATED PHARMA SOLUTIONS LIMITED - 2011-06-22
Standard Industrial Classification
99999 - Dormant Company
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Tangible fixed assets
333,455 GBP2016-03-31
38,507 GBP2015-03-31
Inventory/Stocks
34,985 GBP2016-03-31
12,656 GBP2015-03-31
Debtors
170,555 GBP2016-03-31
168,690 GBP2015-03-31
Cash at bank and in hand
652,070 GBP2016-03-31
469,160 GBP2015-03-31
Current Assets
857,610 GBP2016-03-31
650,506 GBP2015-03-31
Current liabilities
123,430 GBP2016-03-31
158,758 GBP2015-03-31
Net Current Assets/Liabilities
734,180 GBP2016-03-31
491,748 GBP2015-03-31
Total Assets Less Current Liabilities
1,067,635 GBP2016-03-31
530,255 GBP2015-03-31
Non-current liabilities
-114,996 GBP2016-03-31
Provisions for liabilities and charges
-65,666 GBP2016-03-31
-7,701 GBP2015-03-31
Accruals and deferred income
-63,786 GBP2016-03-31
Net assets/liabilities including pension asset/liability
823,187 GBP2016-03-31
522,554 GBP2015-03-31
Called-up share capital
87 GBP2016-03-31
9 GBP2015-03-31
Share premium account
85,668 GBP2016-03-31
85,747 GBP2015-03-31
Retained earnings
737,432 GBP2016-03-31
436,798 GBP2015-03-31
Shareholder's fund
823,187 GBP2016-03-31
522,554 GBP2015-03-31
Cost/valuation of tangible fixed assets
414,266 GBP2016-03-31
66,141 GBP2015-03-31
Depreciation of tangible fixed assets
80,811 GBP2016-03-31
27,634 GBP2015-03-31
Depreciation expense of tangible fixed assets in the period
53,177 GBP2015-04-01 ~ 2016-03-31
Secured debts
148,624 GBP2016-03-31
  • XENOGESIS LIMITED
    Info
    FULLY INTEGRATED PHARMA SOLUTIONS LIMITED - 2011-06-22
    Registered number 07541784
    Discovery Building Biocity, Pennyfoot Street, Nottingham NG1 1GR
    Private Limited Company incorporated on 2011-02-24 (14 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.